The HCPLive Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.
September 7th 2024
These real-world findings highlight the benefits of sustained dupilumab therapy for individuals with chronic rhinosinusitis with nasal polyps.
Tiotropium Improves Lung Function, Regardless of Allergic Status, Study Reports
Adding tiotropium Respimat treatment in adult patients with mild, moderate, and severe asthma who continue to experience symptoms despite the use of maintenance therapies significantly improved lung function, according to a presentation by Boehringer Ingelheim scientists at the 2015 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Houston, TX.
Fears about toxic mold have spawned unqualified and useless testing, both of buildings and people, the US Centers for Disease Control and Prevention says. In a case history of an incident last year, Melody Kawamoto and Elena Page MD describe a costly case that yielded no proof of mold.
Misdiagnosis Likely Due to Virus, Rheumatoid Arthritis Symptom Overlap
February 17th 2015Due to overlapping clinical and immunologic features between Chikungunya virus and rheumatoid arthritis' (RA) symptoms, Washington University in St. Louis researchers warn rheumatologists to be alert for potential misdiagnoses.
Early Research Shows Results with Multiple Sclerosis Vaccine
February 16th 2015In April 2010, Provenge became the first dendritic cell vaccine in cancer treatment to be approved by the US Food and Drug Administration, and the agent is now used in the treatment of metastatic castration-resistant prostate cancer. Insights gleaned from this research are now being applied in the study of a potential vaccine for multiple sclerosis treatment and prevention.
Epilepsy: Neural Antibodies May Indicate Immunotherapy
Epilepsy patients who are not responding to anti-epileptic drugs and who have antibodies binding neural antigens may benefit from immunotherapy. Reporting in the European Journal of Immunology Raffaele Iorio and colleagues at the Institute of Neurology, Catholic University in Rome, Italy detailed their findings.
Cities' Link to Asthma Disputed by Recent Study
February 3rd 2015Challenging previous research, John Hopkins University investigators claimed race, poverty, and ethnicity - not residing in urban areas - were greater forecasters of asthma. However, they cautioned their study did not determine whether location is linked to a worsening in symptoms.
Aterica Digital Health, based in Waterloo, Canada, has designed an EpiPen case that's difficult to lose or leave behind.The "Veta smart case" uses sensors, Bluetooth radios and other technology to broadcast its location and perform several other tricks that could help users survive anaphylaxis. The case itself works with an app that runs on either Apple iOS or Google Android. Whenever a user's smartphone and case get too far apart to communicate, an alert appears on the phone. If a user misplaces a case, the app can reveal its exact location by tracking the signal it emits.
Recent Deaths from Anaphylaxis Underscore Need for Preparedness, Education
Four separate cases of fatal anaphylaxis, all within days of each other, vividly illustrate both the extreme difficulty of avoiding known food allergens and the potential consequences of any given exposure.
Gene-Environment Connection Seen in Peanut Allergy Study
December 15th 2014Infants of a particular generation born in Australia to Asian-born parents appeared to have an increased risk of peanut allergy compared with those of Australian-born parents, according to research published in the December issue of Allergy.